Discover
ADPT
Adaptive Biotechnologies Corporation
22.37
2 x 16.13
2 x 27.46
bid
ask
+
0.92
4.29%
2 @ 05:32 AM
22.37 +0.00 (0.00%)
| Ytd | 37.75% | |
| 1y | 99.91% |
21.40
day range
22.54
9.96
52 week range
22.54
| Open | 21.45 | Prev Close | 21.45 | Low | 21.40 | High | 22.54 | Mkt Cap | 3.58B |
| Vol | 3.28M | Avg Vol | 2.46M | EPS | -0.32 | P/E | N/A | Forward P/E | -88.47 |
| Beta | 2.15 | Short Ratio | 3.46 | Inst. Own | 96.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 15.76 | 200-d Avg | 15.75 | 1yr Est | 20.29 |
| Income Statement | |||
| Total Revenue | 70.87M | ||
| Revenues (USD) | 70.87M | ||
| Cost of Revenue | 18.71M | ||
| Gross Profit | 52.17M | ||
| Operating Expenses | 71.37M | ||
| Research and Development Expense | 23.62M | ||
| Selling, General and Administrative Expense | 47.33M | ||
| Operating Income | -19.21M | ||
| Interest Expense | 2.89M | ||
| Net Income | -20.03M | ||
| Net Income Common Stock | -20.03M | ||
| Net Income Common Stock (USD) | -20.03M | ||
| Consolidated Income | -20.01M | ||
| Net Income to Non-Controlling Interests | 18.00K | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -17.14M | ||
| Earning Before Interest & Taxes (USD) | -17.14M | ||
| Weighted Average Shares | 155.52M | ||
| Weighted Average Shares Diluted | 155.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 80.29M | ||
| Cash and Equivalents (USD) | 80.29M | ||
| Investments | 159.64M | ||
| Investments Current | 140.75M | ||
| Investments Non-Current | 18.89M | ||
| Trade and Non-Trade Receivables | 48.32M | ||
| Current Assets | 291.81M | ||
| Property, Plant & Equipment Net | 71.02M | ||
| Total Assets | 505.94M | ||
| Debt Current | 14.32M | ||
| Total Debt | 208.18M | ||
| Current Liabilities | 87.01M | ||
| Debt Non-Current | 193.86M | ||
| Total Liabilities | 281.70M | ||
| Accumulated Retained Earnings (Deficit) | -1.38B | ||
| Accumulated Other Comprehensive Income | -28.00K | ||
| Shareholders Equity | 216.34M | ||
| Shareholders Equity (USD) | 216.34M | ||
| Assets Non-Current | 214.14M | ||
| Total Debt (USD) | 208.18M | ||
| Deferred Revenue | 50.20M | ||
| Goodwill and Intangible Assets | 120.28M | ||
| Inventory | 11.21M | ||
| Liabilities Non-Current | 194.69M | ||
| Trade and Non-Trade Payables | 9.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.29M | ||
| Net Cash Flow from Financing | 7.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.11M | ||
| Capital Expenditure | -796.00K | ||
| Issuance (Purchase) of Equity Shares | 5.03M | ||
| Net Cash Flow from Investing | 9.14M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.94M | ||
| Net Cash Flow from Operations | -9.54M | ||
| Share Based Compensation | 11.93M | ||